Lista de obras - Julia di Iulio - Dominio Público Uruguay

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

artículo científico publicado en 2010

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study

artículo científico publicado en 2010

Bioinformatics and HIV latency

artículo científico publicado en 2015

Broad betacoronavirus neutralization by a stem helix–specific human antibody

artículo científico publicado en 2021

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

artículo científico publicado en 2021

Deep Sequencing of 10,000 Human Genomes

artículo científico publicado en 2016

Deep sequencing of 10,000 human genomes

artículo científico publicado en 2016

Dynamics of HIV latency and reactivation in a primary CD4+ T cell model

artículo científico publicado en 2014

Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak ⬇️

artículo científico publicado en 2011

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

artículo científico publicado en 2011

Genetic variations in IL28B and allergic disease in children

artículo científico publicado en 2012

Human gene essentiality

artículo científico publicado en 2017

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

artículo científico publicado en 2022

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

artículo científico publicado en 2009

Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution

artículo científico publicado en 2015

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

article

Pharmacogenomics: What is Next? ⬇️

artículo científico publicado el 13 de enero de 2012

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

artículo científico publicado en 2012

Ranking of non-coding pathogenic variants and putative essential regions of the human genome

scientific article published on 20 November 2019

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

artículo científico publicado en 2021

Successful efavirenz dose reduction guided by therapeutic drug monitoring

artículo científico publicado en 2011

Lista de obras de Julia di Iulio

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study

Bioinformatics and HIV latency

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Deep Sequencing of 10,000 Human Genomes

Deep sequencing of 10,000 human genomes

Dynamics of HIV latency and reactivation in a primary CD4+ T cell model

Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak ⬇️

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

Genetic variations in IL28B and allergic disease in children

Human gene essentiality

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

Pharmacogenomics: What is Next? ⬇️

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

Ranking of non-coding pathogenic variants and putative essential regions of the human genome

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Successful efavirenz dose reduction guided by therapeutic drug monitoring

The human functional genome defined by genetic diversity